Company & Sponsor Intelligence
George Washington University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed2
Countries2
Therapeutic footprint
alzheimersdepressionout_of_scopeschizophrenia
Indexed studies
NCT07201389CARE (Chemotherapy Alopecia REduction)
out_of_scope · United StatesNA
out_of_scope · United StatesNA
NCT00786318Ziprasidone vs Standard Therapy for Agitated Patients in the ED
schizophrenia · United StatesPHASE4
schizophrenia · United StatesPHASE4
NCT04282915Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT)
depression · NepalNA
depression · NepalNA
NCT06039267Brain Health & the Microbiome
alzheimers · United StatesCOMPLETED
alzheimers · United StatesCOMPLETED
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →